Pacylex Pharmaceuticals Contact: Michael J. WeickertCEO, Pacylex Pharmaceuticals, Inc.E: michael.weickert@pacylex.com P: 650-218-1840Twitter @Pacylex https://twitter.com/pacylex LinkedIn ...

Digital Pathology Market. In 2023, the digital pathology market is expected to be valued at USD 7,035.8 million USD. By 2033, the market is anticipated to reach USD 24,961.8 milli ...

McKesson Corporation MCK reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $7.07, which beat the Zacks Consensus Estimate of $6.89 by 2.6%. The bottom line also improved 13.5% ...

Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - ...

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical-stage, specialty pharmaceutical company focused on developing and commercializing novel treatments for rare and orphan ...

Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Plus: How AI can help cancer patients avoid unnecessary chemotherapies and make it easier to understand your dental X-rays.

Robert F. Kennedy Jr. would "clear out" entire departments of the Food and Drug Administration that are “not doing their jobs ...

The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.01 per share. Advertisement Article continues below this ad The specialty pharmaceutical company ...

This article discusses continuous manufacturing and the increasing interest of this over traditional batch processing for ...

Ultragenyx Pharmaceutical RARE incurred a third-quarter 2024 loss of $1.40 per share, narrower than the Zacks Consensus ...

Sonrai Analytics (Sonrai), an AI precision medicine company providing advanced analytics to advance therapeutic development, is working to bring its innovative cloud-based AI technology to the Henri & ...